Effectiveness and cost-effectiveness of a tailored text-message programme (MiQuit) for smoking cessation in pregnancy: study protocol for a randomised controlled trial (RCT) and meta-analysis

Rachel Whitemore, Jo Leonardi-Bee, Felix Naughton, Stephen Sutton, Sue Cooper, Steve Parrott, Catherine Hewitt, Miranda Clark, Michael Ussher, Matthew Jones, David Torgerson, Tim Coleman, Rachel Whitemore, Jo Leonardi-Bee, Felix Naughton, Stephen Sutton, Sue Cooper, Steve Parrott, Catherine Hewitt, Miranda Clark, Michael Ussher, Matthew Jones, David Torgerson, Tim Coleman

Abstract

Background: Smoking in pregnancy is a major international public health problem. Self-help support (SHS) increases the likelihood of women stopping smoking in pregnancy and delivering this kind of support by text message could be a cost-effective way to deliver SHS to pregnant women who smoke. SHS delivered by text message helps non-pregnant smokers to stop but the currently available message programmes are not appropriate for use in pregnancy. A randomised controlled trial (RCT) has demonstrated the feasibility and acceptability of using a programme called 'MiQuit' to text SHS support to pregnant women who smoke. Another pilot RCT has shown that it would be feasible to run a larger, multi-centre trial within the UK National Health Service (NHS). The aim of this third RCT is to complete MiQuit's evaluation, demonstrating whether or not this is efficacious for smoking cessation in pregnancy.

Methods/design: This is a multi-centre, parallel-group RCT. Pregnant women aged over 16 years, of less than 25 weeks' gestation who smoke one or more daily cigarettes but smoked at least five daily cigarettes before pregnancy and who understand written English and are being identified in 24 English antenatal care hospitals. Participants are randomised to control or intervention groups in a 1:1 ratio stratified by gestation (< 16 weeks versus ≥ 16 weeks). All participants receive a leaflet on stopping smoking during pregnancy; they are also able to access standard NHS smoking cessation support. Intervention group women also receive the 12-week MiQuit programme of tailored, interactive text message, and self-help cessation support. Women are followed up by telephone at 4 weeks after randomisation and 36 weeks' gestation. The RCT will recruit 692 women (346 per group), enabling a 95% confidence interval for the difference in quit rates to be estimated within ± 3%. To determine whether or not MiQuit helps pregnant smokers to stop, intervention group quit rates from this trial will be combined with those from the two earlier trials in a Trial Sequential Analysis (TSA) meta-analysis to derive a pooled efficacy estimate.

Discussion: If effective, MiQuit will be a cheap, cost-effective method to help pregnant women to stop smoking.

Trial registration: ClinicalTrials.gov, ID: NCT03231553 . Registered on 20 July 2017.

Keywords: Pregnancy; Protocol; Randomised controlled trial; Self-help; Smoking cessation.

Conflict of interest statement

On two occasions since 2008, TC has been paid to attend and present at symposia arranged by Pierre Fabre Laboratories (PFL); PFL is a manufacturer of nicotine replacement therapy.

All other authors have no competing interests.

Figures

Fig. 1
Fig. 1
Schedule of participant assessments
Fig. 2
Fig. 2
Study design, measures and estimated sample

References

    1. Smoking and the Young . A report of a working party of the Royal College of Physicians. London: RCP; 1992.
    1. Batstra L, Hadders-Algra M, Neeleman J. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Hum Dev. 2003;75(1–2):21–33. doi: 10.1016/j.earlhumdev.2003.09.001.
    1. Thapar A, Fowler T, Rice F, Scourfield J, van den BM, Thomas H, Harold G, Hay D. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. AmJ Psychiatry. 2003;160(11):1985–1989. doi: 10.1176/appi.ajp.160.11.1985.
    1. Godfrey C, Pickett KE, Parrott S, Mdege ND, Eapen D. Estimating the costs to the NHS of smoking in pregnancy for pregnant women and infants: University of York: Public Health Research Consortium (PHRC); 2010. . Accessed 25 Apr 2019.
    1. Mohsin M, Bauman AE. Socio-demographic factors associated with smoking and smoking cessation among 426,344 pregnant women in New South Wales, Australia. BMC Public Health. 2005;5:138.
    1. Jensen KE, Jensen A, Nohr B, Kjaer SK. Do pregnant women still smoke? A study of smoking patterns among 261,029 primiparous women in Denmark 1997–2005. Acta Obstet Gynecol Scand. 2008;87(7):760–767. doi: 10.1080/00016340802179814.
    1. Centers for Disease Control and Prevention Smoking during pregnancy—United States, 1990–2002. MMWR Morb Mortal Wkly Rep. 2004;39(53):4.
    1. McAndrew F, Thompson J, Fellows L, Large A, Speed M, Renfrew MJ. Infant Feeding Survey 2010: Health and Social Care Information Centre. 2012.
    1. NHS Digital . Statistics on women’s smoking status at time of delivery. England: April 2016 to March 2017. 2017.
    1. Oncken CA, Dietz PM, Tong VT, Belizan JM, Tolosa JE, Berghella V, Goldenberg RL, Lando HA, Samet JM, Bloch MH. Prenatal tobacco prevention and cessation interventions for women in low- and middle-income countries. Acta Obstet Gynecol Scand. 2010;89(4):442–453. doi: 10.3109/00016341003678450.
    1. Chamberlain C, O'Mara-Eves A, Oliver S, Caird JR, Perlen SM, Eades SJ, Thomas J. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev. 2013;10:CD001055.
    1. Naughton F, Prevost AT, Sutton S, Naughton F, Prevost AT, Sutton S. Self-help smoking cessation interventions in pregnancy: a systematic review and meta-analysis. [Review] [52 refs] Addiction. 2008;103(4):566–579. doi: 10.1111/j.1360-0443.2008.02140.x.
    1. Tappin D., Bauld L., Purves D., Boyd K., Sinclair L., MacAskill S., McKell J., Friel B., McConnachie A., de Caestecker L., Tannahill C., Radley A., Coleman T. Financial incentives for smoking cessation in pregnancy: randomised controlled trial. BMJ. 2015;350(jan27 4):h134–h134. doi: 10.1136/bmj.h134.
    1. Fahy SJ, Cooper S, Coleman T, Naughton F, Bauld L. Provision of smoking cessation support for pregnant women in England: results from an online survey of NHS stop smoking services for pregnant women. BMC Health Serv Res. 2014;14(1):107. doi: 10.1186/1472-6963-14-107.
    1. Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data. Br J Gen Pract. 2014;64(626):e554–e560. doi: 10.3399/bjgp14X681361.
    1. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2015(12):CD010078. 10.1002/14651858.CD010078.pub2.
    1. Bowker K, Campbell KA, Coleman T, Lewis S, Naughton F, Cooper S. Understanding pregnant smokers’ adherence to nicotine replacement therapy during a quit attempt: a qualitative study. Nicotine Tob Res. 2016;18(5):906–12. doi: 10.1093/ntr/ntv205.
    1. Bowker K, Lewis S, Coleman T, Cooper S. Changes in the rate of nicotine metabolism across pregnancy: a longitudinal study. Addiction. 2015;110(11):1827–1832. doi: 10.1111/add.13029.
    1. Dempsey D, Jacob P, III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002;301(2):594–598. doi: 10.1124/jpet.301.2.594.
    1. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.
    1. Abroms LC, Ahuja M, Kodl Y, Thaweethai L, Sims J, Winickoff JP, Windsor RA. Text2Quit: results from a pilot test of a personalized, interactive mobile health smoking cessation program. J Health Commun. 2012;17(Suppl 1):44–53. doi: 10.1080/10810730.2011.649159.
    1. Abroms LC, Boal AL, Simmens SJ, Mendel JA, Windsor RA. A randomized trial of Text2Quit: a text messaging program for smoking cessation. Am J Prev Med. 2014;47(3):242–250. doi: 10.1016/j.amepre.2014.04.010.
    1. Free C, Whittaker R, Knight R, Abramsky T, Rodgers A, Roberts IG. Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tob Control. 2009;18(2):88–91. doi: 10.1136/tc.2008.026146.
    1. Abroms L, Johnson P, Leavitt L, Cleary S, Bushar J, Brandon T, Chiang S. A randomized trial of text messaging for smoking cessation in pregnant women. Am J Prev Med. 2017;53(6):781–790. doi: 10.1016/j.amepre.2017.08.002.
    1. Naughton F, Prevost AT, Gilbert H, Sutton S, Naughton F, Prevost AT, Gilbert H, Sutton S. Randomized controlled trial evaluation of a tailored leaflet and SMS text message self-help intervention for pregnant smokers (MiQuit) Nicotine Tob Res. 2012;14(5):569–577. doi: 10.1093/ntr/ntr254.
    1. Cooper S, Foster K, Naughton F, Leonardi-Bee J, Sutton S, Ussher M, Leighton M, Montgomery A, Parrott S, Coleman T. Pilot study to evaluate a tailored text message intervention for pregnant smokers (MiQuit): study protocol for a randomised controlled trial. Trials. 2015;16(1):29. doi: 10.1186/s13063-014-0546-4.
    1. West R. The clinical significance of ‘small’ effects of smoking cessation treatments. Addiction. 2007;102(4):506–509. doi: 10.1111/j.1360-0443.2007.01750.x.
    1. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13–25. doi: 10.1080/1462220031000070552.
    1. West R, Hajek P, Stead L, Stapleton J, West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3):299–303. doi: 10.1111/j.1360-0443.2004.00995.x.
    1. Naughton F, Cooper S, Foster K, Emery J, Leonardi-Bee J, Sutton S, Jones M, Ussher M, Whitemore R, Leighton M, et al. Large multicentre pilot randomised controlled trial testing a low-cost, tailored, self-help smoking cessation text message intervention for pregnant smokers (MiQuit) Addiction. 2017;112:1238–1249. doi: 10.1111/add.13802.
    1. Ferguson J, Docherty G, Bauld L, Lewis S, Lorgelly P, Boyd KA, McEwen A, Coleman T. Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial 3. BMJ. 2012;344:e1696. doi: 10.1136/bmj.e1696.
    1. Benowitz N, Hukkanen J, Jacob III P. Nicotine chemistry, metabolism, kinetics and biomarkers. In: Henningfield J, London E, Pogun S, editors. Nicotine Psychopharmacology. Berlin Heidelberg: Springer; 2009;192:29–60.
    1. Hegaard HKK. Determination of a saliva cotinine cut-off to distinguish pregnant smokers from pregnant non-smokers. Acta Obstet Gynecol Scand. 2007;86(4):2007. doi: 10.1080/00016340601147517.
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64–75. doi: 10.1016/j.jclinepi.2007.03.013.
    1. Metcalfe C. Statistical power: still an essential element in sample size calculation. BMJ. 2009;339:b3985. doi: 10.1136/bmj.b3985.
    1. Van Hout B, Janssen M, Feng Y, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–715. doi: 10.1016/j.jval.2012.02.008.
    1. Jones MJ. The development of the Economic impacts of Smoking In Pregnancy (ESIP) model for measuring the impacts of smoking and smoking cessation during pregnancy. Nottingham: University of Nottingham; 2015.
    1. Jones M, Lewis S, Parrott S, Wormall S, Coleman T. Re-starting smoking in the postpartum period after receiving a smoking cessation intervention: a systematic review. Addiction. 2016;111(6):981–90. doi: 10.1111/add.13309.
    1. Jones M, Lewis S, Parrott S, Coleman T. Systematic critical review of previous economic evaluations of smoking cessation during pregnancy. BMJ Open. 2015;5(11):e008998. doi: 10.1136/bmjopen-2015-008998.
    1. National Institute for Health and Clinical Excellence . Developing NICE guidelines: the manual. 2017.
    1. Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
    1. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford: Oxford University Press; 2014.
    1. Emery J, Coleman T, Sutton S, Cooper Sue E, Leonardi Bee J, Jones M, Naughton F. Uptake of tailored text message smoking cessation support in pregnancy when advertised on the internet (MiQuit): Observational study. J Med Internet Res. 2018;20(4):146.
    1. Naughton F, Cooper S, Bowker K, Campbell K, Sutton S, Leonardi-Bee J, Sloan M, Coleman T. Adaptation and uptake evaluation of an SMS text message smoking cessation programme (MiQuit) for use in antenatal care. BMJ Open. 2015;5(10):e008871. doi: 10.1136/bmjopen-2015-008871.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir